- JP-listed companies
- KNC Laboratories Co., Ltd.
- Financials
- Net income margin (%)
KNC Laboratories Co., Ltd. (6568)
Market cap
¥9.5B
P/E ratio
15.7x
Develops and manufactures specialized organic chemicals for pharmaceutical, electronics, and biotech companies to accelerate their product development.
| Period End | Net income margin (%) | YoY (%) |
|---|---|---|
| Mar 31, 2025 | 9 | -44.72% |
| Mar 31, 2024 | 16.3 | -8.80% |
| Mar 31, 2023 | 17.9 | +106.77% |
| Mar 31, 2022 | 8.6 | +30.45% |
| Mar 31, 2021 | 6.6 | -18.84% |
| Mar 31, 2020 | 8.2 | -45.12% |
| Mar 31, 2019 | 14.9 | +4.30% |
| Mar 31, 2018 | 14.3 | +40.50% |
| Mar 31, 2017 | 10.2 | +328.82% |
| Mar 31, 2016 | 2.4 | -50.39% |
| Mar 31, 2015 | 4.8 | -33.60% |
| Mar 31, 2014 | 7.2 |